At the Oldie, Dalrymple outlines the problems of new blood tests for Alzheimer’s disease:

By the time they are in their 80s, almost a third of people will test positive for the disease who do not, and never will, have it. The damage done to such people and their relatives might be considerable, at least if the tests were used as screening instruments.